Cancer patients receiving chemotherapeutic treatments routinely experience a wide range of distressing side effects, including nausea, vomiting, and dysphoria. Such symptoms often compromise patients 1 quality of life and may lead to the decision to postpone or even reject future, potentially life-saving, treatments. In this article, we discuss the hypotheses that have been offered to explain the development of such symptoms. We also review, in greater detail, the research evidence for the efficacy of five treatments for such symptoms: hypnosis, progressive muscle relaxation training with guided imagery, systematic desensitization, attentional diversion or redirection, and biofeedback. We discuss the implications of this treatment research, paying particular attention to factors associated with treatment outcome, mechanisms of treatment effectiveness, and issues associated with clinical application.
gain can come at considerable short-term cost to the cancer patient in the form of aversive and debilitating side effects. Among the more common drug-induced side effects are alopecia, stomatitis, immunosuppression, anorexia, nausea, and vomiting.
In addition to these pharmacological side effects, chemotherapy patients also experience psychological side effects.
Psychological side effects, which should not necessarily be regarded as abnormal or indicative of psychopathology, are those that cannot be attributed directly to the antineoplastic medications; instead, such symptoms are believed to result from psychological processes (e.g., learning) that occur in the chemotherapy context. These symptoms can occur before chemotherapy (in which case they are referred to as anticipatory side effects) as well as during and after the actual chemotherapy infusion. When they occur after chemotherapy has been administered (and while the drugs remain pharmacologically active within the system), it is practically impossible to distinguish We wish to thank Kate B. Carey and the anonymous reviewers for their many helpful suggestions on an earlier draft of this review. The writing of this manuscript was supported in part by Grant No. 25516 from the National Cancer Institute, Grant No. PBR-29 from the American Cancer Society, and Grant No. 24 from Syracuse University.
Correspondence concerning this article should be addressed to Michael P. Carey, Department of Psychology, 430 Huntington Hall, Syracuse University, Syracuse, New York 13244; or to Thomas G. Burish, 221 Kirkland Hall, Vanderbilt University, Nashville, Tennessee 37240. such psychological side effects from their pharmacological counterparts. Unfortunately, there has been much inconsistency in the literature concerning the definition of these symptoms and the terminology used to describe them. For the most part, however, research with humans has focused on three symptoms, namely, nausea, vomiting, and dysphoria. However, it should be noted that considerable animal research and recent human research have also focused on other side effects of cancer treatments, especially learned side effects such as conditioned taste and food aversions (e.g., Bernstein & Borson, 1986; Smith, Blumsack, & Bilek, 1985) and conditioned immunosuppression (e.g., Ader, 198 l; Ader& Cohen, 1985) . These phenomena may develop through mechanisms that are similar to those that are the focus of this article.
Symptoms such as nausea, vomiting, and dysphoria are not only frequent among cancer chemotherapy patients but can also be extremely stressful. In addition to the physical and affective distress they cause, many patients are embarrassed by their display of symptoms (e.g., anticipatory vomiting), and others even fear for their sanity. In fact, some patients eventually discontinue chemotherapy, abandoning the hope for remission and cure rather than suffer from such symptoms (Wilcox, Petting, Nettesheim, & Abeloff, 1982) . It has been suggested that still other patients will turn to ineffective and expensive "quack" treatments rather than tolerate the paradoxical worsening quality of life that chemotherapy can bring. Consequently, oncologists (e.g., Laszlo & Lucas, 1981) , oncology nurses (e.g., Oberst, 1978) , and cancer patients themselves (e.g., Cohn, 1982) have all implored researchers to identify an effective treatment for the side effects associated with cancer chemotherapy.
Pharmacological agents (e.g., prochlorperazine, delta-9-tetrahydrocannabinol) have been used to control the psychological responses to chemotherapy, but standard antiemetics have been found largely ineffective for this type of symptom (Laszlo, 1983;  Morrow, Arseneau, Asbury, Bennett, & Boros, 1982) . In addition, there is evidence that these medications can actually worsen the symptomatology under some conditions (Zeltzer, LeBaron, & Zeltzer, 1984a) . Moreover, even when antiemetics provide some relief, they often have side effects of their own (e.g., sedation, dystonic reactions) or administration demands (e.g., the need for inpatient hospitalization) that limit their acceptance or usefulness among some patients. The ineffectiveness, the paradoxical worsening of symptoms, and the practical limitations of pharmacological agents have all prompted researchers to consider psychological treatments as an alternative method of controlling such symptoms.
In recent years, research on the etiology and treatment of anticipatory and exacerbatory side effects of cancer chemotherapy has burgeoned and has attracted researchers from several health-care disciplines. This increasingly widespread interest is based on at least two primary factors. First, from a theoretical point of view, the psychological side effects of cancer chemotherapy present an unusual opportunity to study the natural development of reactions to repeated aversive treatment within a clinical population. As we shall see, these reactions share some commonalities with other aversive responses but also appear to have some notable differences. Second, from a clinical point of view, these side effects are quite prevalent and can be aversive and debilitating. As a result, they represent an important clinical problem.
The primary purpose of this article is to review the research evidence on the etiology and treatment of the most common psychological side effects associated with cancer chemotherapy, namely, nausea, vomiting, and dysphoria. We begin with an overview and evaluation of the etiological formulations that have been proffered to explain the development of such symptoms. After this discussion of etiology, we review and critique the treatment literature, focusing on investigations that provide quantitative outcome data. We discuss the implications of this research, paying particular attention to patient factors associated with outcome, hypothesized mechanisms by which the treatments may exert their impact, and clinical issues in the application of such interventions.
Etiology of Psychological Side Effects Associated
With Cancer Chemotherapy
Psychological side effects are believed to be relatively common. For example, prevalence data obtained from prospective, longitudinal studies indicate that approximately 45% of adult cancer patients experience nausea, vomiting, or both in the 24 hr preceding their chemotherapy (Burish & Carey, 1986) , Although precise estimates of the prevalence of postchemotherapy psychological side effects in adults are not available, they are believed to be even more common (Burish & Carey, 1986) .
Several causal explanations have been offered to explain the development of psychological side effects. One hypothesis is that these symptoms "may be surfacing manifestations of underlying psychological readjustment problems, associated with lifethreatening illness" (Chang, 1981, p. 707) . This view suggests that nonpharmacological symptoms represent the negative affect that patients harbor toward their chemotherapy treatments. To date, no data are available to support this assertion. A second hypothesis is that patients may display such symptoms in order to gain attention and sympathy. Inconsistent with this hypothesis, however, is the observation that the punishing side effects of chemotherapy far outweigh any secondary gains that may be realized by cancer patients; moreover, there are no data to support the notion that removal of attention can reduce nonpharmacological symptoms. A third hypothesis is that the observed symptoms may "be produced by brain metastasis or local cancer involvement of the gastrointestinal tract" (Chang, 1981, p. 707) . Although this explanation may be accurate for a few patients, it has been ruled out as an explanation for most patients (e.g., Morrow, 1982) .
In contrast with the first three hypotheses, which are speculative and lack empirical support, the fourth hypothesis has been supported by the research literature. This hypothesis holds that nonpharmacological or psychological side effects develop through an associative learning process. According to the most widely accepted conditioning viewpoint, after one or more pairings, an association is established between the pharmacological side effects (the unconditioned responses; UCRs) caused by the chemotherapy (the unconditioned stimulus; UCS) and various stimuli (e.g., sights, smells, thoughts; the conditioned stimuli; CSs) associated with the chemotherapy setting. As a result of repeated associations, the CSs begin to elicit nausea, vomiting, and dysphoria (the conditioned responses; CRs), even in the absence of the UCS. Two variations of the conditioning model have also been suggested. The first, proposed by Leventhal, Easterling, Nerenz, and Love (1988) , is that postchemotherapy nausea and vomiting might occasionally serve as the UCS, with responses to this nausea and vomiting (e.g., anxiety and secondary nausea occurring later in time) being the UCRs. These UCRs then become conditioned to various stimuli in the chemotherapy environment and thereby take the form of CRs. Thus, in this first variation of the conditioning model, the morphology of the CS and CR is similar to that of the original model, but the UCS and UCR are not. The second variation was suggested by Garcia y Robertson and Garcia (1985) , who believe that conditioned responses to cancer chemotherapy may develop through a process that closely resembles taste aversion learning. Although the published literature on conditioned responses to cancer chemotherapy has been based almost exclusively on the first model of conditioning, it should be noted that these two variations do provide viable conceptualizations of alternative, though not necessarily mutually exclusive, processes.
There are several sources of data that converge to support the hypothesis that associative learning is the primary phenomenon underlying the etiology of psychological symptoms. In no case were the data generated by experimental research that was designed deliberately to induce conditioned nausea and vomiting in cancer chemotherapy patients through controlled experimental manipulations, a procedure that would be ethically unacceptable. Rather, the data are based on analogous phenomena or experimental outcomes that consistently, logically, or exclusively point to associative learning as the most reasonable explanation. At least four sources of supporting data can be identified.
First, the symptoms that are displayed by chemotherapy pa-tients have several topographical similarities to those of laboratory animals that ingest a gastrotoxic substance or that are irradiated while eating a certain food. The animals subsequently avoid that substance or food during future feedings, a phenomenon referred to as learned taste aversion (for an extended discussion of the similarities of conditioned nausea and vomiting in cancer patients and learned taste aversions, see Garcia y Robertson & Garcia, 1985) . The symptoms have been shown to result from a learning process that is associative in nature, although it deviates, as does the conditioned response of chemotherapy patients, from the traditional classical conditioning paradigm in some interesting respects (e.g., the symptoms often develop after only one or a few associations and despite the fact that there may be several hours between the UCS and UCR). Another example of documented animal conditioning that bears even closer resemblance to the chemotherapy situation was demonstrated by Collins and Tatum (1925) and Pavlov (1927) . These investigators showed that dogs repeatedly injected with an emetic drug developed conditioned vomiting in response to stimuli associated with the injection. Second, several human studies provide data that support an associative learning explanation. For example, I. L. Bernstein and her colleagues (e.g., I. L. Bernstein, 1978; I. L. Bernstein & Webster, 1980) demonstrated experimentally that taste aversions can develop in chemotherapy patients as a result of the emetic properties of the infused drugs. For example, in one study the investigators assigned pediatric cancer patients receiving emetogenic chemotherapy agents to one of two groups: to an experimental group that received a novel-flavored ice cream shortly before their scheduled drug treatment or to a control group that did not receive the ice cream. A second control group of patients receiving nonemetic chemotherapy drugs was also included. After 2 or more weeks, patients in all groups were offered either some of the novel-flavored ice cream or an opportunity to play with a game. Patients in the two control groups overwhelmingly chose the ice cream; patients in the experimental group showed an aversion to the ice cream, generally preferring the game. Similar results were subsequently demonstrated in adult cancer patients (see I. L. Bernstein & Webster, 1985 , for a review).
Third, there have been reports of cancer chemotherapy patients becoming conditioned to antiemetic treatments. In these situations, the antiemetic was apparently given each time the patient became nauseated or was vomiting; as a result, it became associated with nausea and vomiting and later was able to elicit, on its own, nausea and vomiting. For example, Kutz, Borysenko, Come, and Benson (1980) reported the case of a patient with neurofibrosarcoma who smoked marijuana to alleviate severe nausea and vomiting. After chemotherapy was discontinued, the smell of marijuana in social situations elicited nausea and vomiting. In another case reported by the same authors, the marijuana was administered in brownies and cookies. For a year after the chemotherapy was discontinued, the taste or sight of these foods produced nausea. Similar conditioning to antiemetics has been reported by other investigators (e.g., Morrow etal., 1982) .
Fourth, research has shown that factors related to the development of conditioned symptoms in cancer chemotherapy patients conform to the principles of associative learning. For example, Andrykowski et al. (in press) and Andrykowski, Redd, and Hatfield (1985) conducted two longitudinal studies of the development of anticipatory nausea in cancer chemotherapy patients. In these investigations, which together involved the study of over 150 patients, the authors found that anticipatory nausea never occurred without the prior occurrence of postchemotherapy nausea, that is, consistent with the principles of associative learning, the presence of a UCR was necessary for the acquisition of a CR. Moreover, after a careful analysis of other factors that contributed to the development of anticipatory symptoms, the authors concluded that, consistent with an associative learning model, "all of the factors that reliably predicted the development of AN [anticipatory nausea] were either directly or indirectly linked to the magnitude" of the unconditioned symptoms (Andrykowski et al., in press, p. 11) . As has been noted elsewhere (Burish & Carey, 1986) , other descriptive data on the development and nature of conditioned responses in cancer chemotherapy patients also consistently conform, in prospective as well as retrospective studies, to the principles of associative learning.
In addition to supporting the conditioning model, the available data suggest that several factors can serve to mediate or potentiate the learning process and thereby produce considerable variation in symptom development. These individual difference factors may arise independently of, but nonetheless contribute to, the development of conditioned responses.
One major individual difference may be proneness to nausea and vomiting. Research has suggested that patients who have a history of motion sickness or of experiencing nausea and vomiting to various foods or situations (e.g., pregnancy) are more likely to report posttreatment and anticipatory nausea and vomiting in response to cancer chemotherapy (Jacobsen et al., 1988; Morrow, 1985) . Morrow (1985) has suggested that there is a neurological basis for this relationship. The experience of nausea and vomiting is thought to result from activation of the "vomiting center," located in the lateral reticular formation of the medulla oblongata (Borison & McCarthy, 1983) . The vomiting center has four major inputs, including one from the vestibular system, which is thought to play a role in motion sickness. It has been suggested that in addition to affecting the other major inputs, chemotherapy may affect the vestibular system, which in patients with a susceptibility to motion sickness may lead to additional stimulation of the vomiting center and therefore an increased likelihood of nausea and vomiting (Morrow, 1985) . Redd and his colleagues (Jacobsen et al., 1988; Andrykowski et al., in press) have suggested that there may be constitutional differences in cancer patients' susceptibility to gastrointestinal distress, including that due to chemotherapy. Patients with a greater constitutional vulnerability to gastrointestinal distress may be more likely to respond to chemotherapy with high levels of posttreatment nausea and vomiting, which in turn increases the likelihood that they will develop conditioned nausea and vomiting, in comparison with patients without this diathesis. In summary, the data suggest that patients with a past history of nausea and vomiting resulting from motion sickness, certain foods, or other experiences are more likely to develop conditioned nausea and vomiting in response to cancer chemotherapy.
A second major factor that appears to affect the development of conditioned responses to chemotherapy is a patient's anxiety level. 1 Specifically, state anxiety levels have been positively related to the presence of conditioned responses in a number of retrospective studies (e.g., Ingle, Burish, & Wallston, 1984; van Komen & Redd, 1985) and prospective investigations (e.g., Andrykowski et al., 1985, in press; Nerenz, Leventhal, Easterling, & Love, 1986) . For example, Nerenz et al. (1986) interviewed cancer patients before each of their first six treatment cycles.
The authors found that the incidence of anticipatory nausea was related to the level of pretreatment anxiety: for mildly anxious patients the incidence averaged 9.8%; for highly anxious patients the incidence was approximately twice as much, averaging 18.1%. Andrykowski et al. (1985) found that a patient's According to this explanation, highly anxious patients condition more quickly than do less anxious patients (e.g., Spence, 1958) . Data recently reported by Andrykowski and Redd (1987) conflict with this explanation, however. These authors interviewed patients before each of their chemotherapy treatments to determine pretreatment anxiety levels and pre-and posttreatment nausea levels. They found that patients who developed anticipatory symptoms late in the course of chemotherapy (i.e., after their seventh treatment) generally had higher anxiety levels during all treatments than did patients who developed anticipatory symptoms early in the treatment course. Andrykowski and Redd (1987) also noted that late-onset patients generally had lower posttreatment nausea levels until the session just before they developed anticipatory nausea, at which time their posttreatment levels increased substantially. The authors speculated that the heightened pretreatment anxiety levels eventually led to the increased posttreatment nausea and that once posttreatment nausea increased, patients were more likely to develop anticipatory symptoms (i.e., the greater the intensity of the unconditioned response, the more likely the development of a conditioned response).
Others have focused on different parameters in trying to explain the relationship between anxiety and conditioning. Dolgin, Katz, McGinty, and Siegel (1985) , for example, have suggested that highly anxious patients tend to show high levels of vigilance to their environments and, as a result, tend to notice more closely various stimuli in the clinic setting. Such attention increases the likelihood that these stimuli will develop into CSs.
They found that consistent with this hypothesis, pediatric cancer patients with anticipatory symptoms attended to and processed more stimuli in their environments, and habituated to these stimuli more slowly, than did matched patients without anticipatory symptoms.
Although most of the speculation about the relationship be- As a result of this enhanced propensity, a variety of stimuli will more readily cause gastrointestinal upset in the future.
In the second stage, increased noradrenergic activity, caused by the heightened anxiety or stress levels, contributes to the development of anticipatory nausea and vomiting in patients with the increased propensity. The process by which the increased noradrenergic activity leads to these effects is as yet undeter- Although associative learning appears to play an important role in the etiology of psychological side effects, we propose that side effects in the chemotherapy context might also result from, or be exacerbated by, a fifth mechanism, namely, psychological stress (i.e., the process that occurs when a person appraises a situation or stimulus as taxing his or her resources and endangering his or her well-being; Lazarus & Folkman, 1984) . Thus, we hypothesize that a person who appraises the chemotherapy process as threatening or who is unprepared to cope with its demands might experience negative outcomes (e.g., dysphoria, nausea). It is important to emphasize that by psychological stress we are referring broadly to the appraisal and coping process, not solely to an affective state that results from that process (e.g., increased anxiety). In addition to initiating symptoms, psychological stress can worsen already existing (i.e., pharmacological and conditioned) symptoms. Thus, stress can play a role at almost any stage in the development and expression of psychological symptoms to cancer chemotherapy. Support for the role of stress in psychological symptoms comes both from the general stress literature (e.g., Lazarus, 1966; Lazarus & Folkman, 1984; Selye, 1976) and from empirical work conducted specifically in the chemotherapy context (e.g., Nerenz, Leventhal, & Love, 1982; Nerenz, Leventhal, Love, & Ringler, 1984) . Unfortunately, most investigators have focused either on the role of associative learning or on the role of stress in accounting for the development of psychological symptoms, although there have been exceptions (e.g., Nerenz et al., 1982) . In the end, however, we suspect that both processes are implicated, perhaps in a synergistic way.
In summary, five explanations have been put forward to explain the development of psychological symptoms in the chemotherapy context. Our review and interpretation of the literature leads us to conclude that many of these symptoms, espe- we do not include such interventions in our review because they
have not yet been subjected to controlled research.
Hypnosis
Hypnosis was probably the first psychological technique used to control the side effects associated with chemotherapy and is still the most widely used procedure with children and adolescents. Our review of this literature suggests that the term hypnosis does not describe a specific technique as much as it refers to a number of induction procedures that require that the patient be completely attentive and absorbed in an activity prescribed or directed by the therapist. This activity may be purely cognitive, or it may include both cognitive and behavioral components. Hypnotic induction procedures may involve psychological quiescence (i.e., relaxation) and augmented suggestibility (cf. Wadden & Anderton, 1982) , although these characteristics have not been reported universally in the cancer chemotherapy literature. For example, when used with children, hypnosis is usually characterized by a heavy reliance upon the use of playful fantasy rather than on the more passive images of natural beauty that are frequently used with adults; moreover, hypnotic imagery with children is often accompanied by physical movement and the use of toys and dolls, both of which may actually increase physiological arousal (Zeltzer & LeBaron, 1986 ). In 2 It is possible that the treatments reviewed decrease pharmacological side effects as well as conditioned and stress-related symptoms; however, it is practically impossible to separate out these differential effects when measuring postchemotherapy outcome measures. Many researchers who use psychological interventions have assumed, conservatively, that postchemotherapy symptom reductions resulting from these interventions reflect only the diminuation of psychologically produced symptoms.
contrast, when used with adult patients, hypnosis typically involves an induction procedure that is designed to produce deep physiological relaxation (e.g., Redd, Andresen, & Minagawa, 1982) and often employs imagery and suggestions related to natural beauty and serenity. Operationally, Redd (1985 Redd ( /1986 has noted that "the procedures for inducing passive relaxation are identical to those frequently used by many professionals who identify their procedures as hypnosis" (p. 21).
The early research on hypnosis with children (e.g., LaBaw, Holton, Tewell, & Eccles, 1975) , adolescents (e.g., Ellenberg, Kellerman, Dash, Higgins, & Zeltzer, 1980) , and adults (e.g., Dempster, Balson, & Whalen, 1976) suggested that hypnosis could reduce nausea, vomiting, pain, and the negative emotions associated with chemotherapy. Though encouraging, this early research was more heuristically than empirically valuable because it did not report objective data, use statistical analyses, or employ adequate methodological controls.
The controlled work with hypnosis is summarized in Table   1 ; the most programmatic set of studies has been conducted by
Zeltzer and her colleagues with pediatric patients. These studies have either used hypnosis patients as their own controls (Le- Baron & Zeltzer, 1984; Zeltzer, Kellerman, Ellenberg, & Dash, 1983) or compared them to patients receiving supportive counseling (Zeltzer, LeBaron, & Zeltzer, 1984b) . Overall, this series of studies suggests that after one to three training sessions, patients receiving hypnosis reported reduced levels of postchemotherapy nausea and vomiting and that any postchemotherapy side effects that did remain were less bothersome than they were prior to training. Moreover, these benefits continued after training when the therapist was no longer present. No data on anticipatory symptoms were reported.
In the only hypnosis study to include a no-treatment control group, Cotanch, Hockenberry, and Herman (1985) compared 6 children given hypnosis plus standard antiemetic treatment with 6 children who received the standard antiemetic treatment alone. Results indicated that patients receiving hypnosis experienced reductions in the intensity and severity of both nausea and vomiting and an increase in food intake after chemotherapy, in comparison with patients receiving standard procedures.
Finally, in the only controlled study to use hypnosis with adults, studied 6 patients who had experienced anticipatory nausea and vomiting prior to at least their last three chemotherapy treatments. After completing two training sessions, the patients underwent chemotherapy while hypnotized. All 6 patients reported decreased nausea and were observed by nurses to have ceased all vomiting prior to and during the chemotherapy sessions in which hypnosis was used.
When the patients did not use hypnosis during subsequent chemotherapy sessions, the anticipatory symptoms returned. No data on postchemotherapy symptoms were reported.
Overall, it appears that hypnotic procedures are an effective intervention for reducing both anticipatory and postchemotherapy nausea and vomiting and the negative affects associated with chemotherapy. Continued research is needed to replicate these findings, especially in adults. In this regard, it is important that investigators state explicitly which induction techniques and procedures they have used. Moreover, two points should be made regarding the use of hypnosis with cancer patients. First, not all patients will accept hypnosis (Hendler & Redd, 1986; Redd & Andrykowski, 1982; Zeltzer et al., 1983) . Reasons for rejection typically have involved misperceptions about the process of hypnosis and potential posthypnotic effects. In an attempt to sidestep such concerns, Redd and his colleagues now refer to their hypnosis procedure as passive relaxation training with guided imagery, and they report greater acceptance by patients as a result of this change (W. H. Redd, personal communication, January 22, 1988) . Second, in the only study that has compared hypnosis to an alternate treatment, it was found that adolescent patients who received hypnosis did not improve more than patients who received supportive counseling (Zeltzer et al., 1984b) . Thus, although hypnosis may be effective, some people may not accept it, and others may be treated as effectively with alternate procedures.
Progressive Muscle Relaxation Training With Guided Imagery
Although hypnosis was probably the first psychological technique to be used in the chemotherapy context, progressive muscle relaxation training (PMRT) is the most widely researched technique. 3 PMRT is based on a series of muscle tensing and relaxing exercises developed by Jacobson (1938) and later modified by D. A. Bernstein and Borkovec (1973) , among others.
This procedure is sometimes referred to as active relaxation training because it includes a muscle tensing component. Relaxation training procedures that do not include a tensing component have also been used in the chemotherapy context and are generally referred to as passive relaxation procedures. In the cancer chemotherapy context, PMRT has usually been supplemented with guided imagery during the infusion period; guided imagery involves the use of a sequence of thoughts and mental pictures to facilitate relaxation (see Turk, Meichenbaum, & Genest, 1983, pp. 285-291 , for examples of relaxation imagery). In most of the research reported in this area, the imagery is individualized to each patient on the basis of a preintervention interview.
As with hypnosis, uncontrolled case reports of the use of PMRT and guided imagery with cancer chemotherapy patients are available (e.g., Hamberger, 1982; Scott, Donahue, Mastrovito, & Hakes, 1983) . These reports provide little more than suggestive evidence for the efficacy of relaxation training and guided imagery. Fortunately, controlled research on PMRT and guided imagery has been ample and provides stronger data.
The controlled research on PMRT and guided imagery is summarized in Table 2 ; this research has been conducted almost exclusively with adults and has focused on the psychological side effects and distress that occur during and after chemotherapy injections. Burish and his colleagues have completed five studies on the effectiveness of PMRT and guided imagery.
3 Relaxation is a broad term that has been used to refer to a disparate array of activities, including watching television, taking a cruise, and lying on a beach. These pleasurable activities may or may not result in physiological quiescence, the hallmark of progressive muscle relaxation training. Note. N = nausea; V = vomiting; RN = registered nurse; Pt = patient; Dx = diagnosis; CP = chemotherapy protocol; BP = blood pressure.
The initial report was a single-subject investigation (Burish & Lyles, 1979) , which was followed by a series of four group comparison designs (Burish, Carey, Krozely, & Greco, 1987; Lyles, Burish, Krozely, & Oldham, 1982) . In all of these studies, patients were trained in PMRT and guided imagery during the 30 min just prior to the chemotherapy injections and underwent chemotherapy while relaxed. Patients were asked to practice PMRT and guided imagery at home between treatments. Measurement of patient benefit included a number of physiological, self-report, and nurse-observation measures, which were collected during three to five training and follow-up sessions.
Overall, the research has demonstrated that training in PMRT and guided imagery can reduce physiological arousal, patient reports of nausea and dysphoria, and nurse reports of nausea and anxiety. In some studies, PMRT-related reductions in vomiting frequency were also observed, although this has not been a consistent finding, largely because of the low baseline frequency of this symptom (e.g., see Lyles et al., 1982) . The gains achieved with PMRT and guided imagery have been observed in comparison with untreated control patients (e.g., and with placebo control patients (Lyles et al., 1982) . Typically, these effects were most salient during and after the chemotherapy infusions as opposed to before the infusions. Moreover, the benefits obtained during therapist-guided training were usually stronger than those achieved during follow-up (i.e., maintenance) sessions when the patient was asked to relax him or herself. Finally, PMRT and guided imagery were Note. N = nausea; V -vomiting; RN -registered nurse, Pt = patient; Dx = diagnosis; CP = chemotherapy protocol; PMRT = progressive muscle relaxation training; GI = guided imagery; BP = blood pressure; PR = pulse rate; RR = respiration rate; SBP -systolic blood pressure; DBF = diastolic blood pressure.
shown to be effective not only in ameliorating distress in veteran chemotherapy patients (e.g., Lyles et al., 1982) but also in preventing or at least delaying the apparent development of psychological side effects in new patients . Cotanch and her associates have also conducted research that supports the efficacy of PMRT and guided imagery. The first study (Cotanch, 1983) used an own-control design in which 12 adult patients underwent one baseline chemotherapy session followed by five chemotherapy sessions during which they were trained in PMRT with guided imagery. Results indicated that PMRT and guided imagery produced reductions in physiological arousal, nausea, vomiting, and anxiety in 9 of 12 patients. In a follow-up study (Cotanch & Strum, 1985) , PMRT and guided imagery delivered by audiotaped instructions were compared to a placebo treatment (therapist present while patient listened to music). The relaxation procedure was found to be more effective than the placebo tape in lowering physiological arousal and trait anxiety and in increasing postchemotherapy caloric intake. Unfortunately, no standard treatment control group was included in this study, making evaluation of the audiotaped instructions difficult.
Finally, Dahlquist, Gil, Armstrong, Ginsberg, and Jones (1985) reported on the use of cue-controlled muscle relaxation, controlled breathing, pleasant imagery, and positive self-statements with 3 children in a multiple baseline design. After this treatment, behavioral distress as observed by trained assistants was reduced 46-68% from baseline levels. Medical staff ratings of the patient's distress and patient self-reports of distress were also reduced as a result of treatment.
In summary, PMRT and guided imagery have been shown in several well-controlled investigations to be effective for the reduction of nausea, physiological arousal, and negative affect and for increasing food intake during the days after chemotherapy. Reductions in vomiting have not been consistently reported, although this may reflect less severe baseline symptoms in the patients studied. Finally, the effects of PMRT and guided imagery appear to be strongest during training, although modest benefits have also been observed during follow-up.
Systematic Desensitization
Systematic desensitization (SD) is a procedure that has been used widely in the treatment of phobias, sexual dysfunctions, and other anxiety-related disorders (Wolpe, 1958) . The procedure basically consists of teaching a patient a relaxation skill, commonly some form of relaxation training, and then exposing the patient to progressively more anxiety-provoking stimuli. The goal is to have these stimuli elicit or be accompanied by a relaxation response rather than the anxiety response heretofore elicited by them. The underlying process responsible for the effectiveness of SD has been a topic of considerable recent debate; hypothesized mechanisms of action include counterconditioning, extinction, habituation, attentional control, and several others (see Masters, Burish, Hollon, & Rimm, 1987 , for a review). Note. N = nausea; V = vomiting; AN = anticipatory nausea; AV = anticipatory vomiting; RN = registered nurse; Pt = patient; Dx • CP = chemotherapy protocol; PMRT = progressive muscle relaxation training; SD = systematic desensitization.
diagnosis;
Support for the use of SD with cancer chemotherapy patients comes from both uncontrolled case studies (e.g., Hailey & White, 1983; Hoffman, 1982 Hoffman, -1983 West & Piccionne, 1982) and from controlled research (summarized in Table 3 ). Morrow and Morrell (1982) studied 60 patients within a group comparison format to determine the relative efficacy of a self-control version of systematic desensitization, supportive counseling, and no treatment. Patients in the SD condition were taught PMRT and instructed to imagine themselves staying calm and relaxed in a number of situations, beginning with the day before chemotherapy and progressing through the actual chemotherapy infusion. Patients were seen twice in the therapist's office and were then followed for two subsequent chemotherapy sessions. During follow-up, the patients receiving SD reported reduced frequency and severity, and a shortened duration, of both anticipatory nausea and vomiting, in comparison with counseling and control patients.
In a subsequent report, Morrow (1986) compared patients who received SD, counseling, or no treatment (most of the patients in these groups were the same as those participating in the Morrow & Morrell, 1982 , study) with a new group of patients that received PMRT only. The procedures used for the first three groups were identical to those used in the Morrow and Morrell study; the PMRT group followed procedures identical to those of the SD group except that no cognitive hierarchy was used. The results suggested that SD reduced anticipatory nausea, state anxiety, and trait anxiety 4 more than the other three treatments did; these other treatments did not differ from each other on these variables. SD and PMRT produced changes in posttreatment nausea and vomiting that were comparable and significantly greater than those produced by the counseling or no treatment groups, which did not differ from each other.
Because Morrow (1986) used different procedures to administer PMRT from those of other researchers (e.g., guided imagery was not given, and relaxation was not provided during chemotherapy treatments, nor were patients specifically told to use the relaxation during their treatments), he appropriately cautioned against viewing this study as a direct comparison of SD and PMRT. However, the data do suggest that SD is less effective without the cognitive hierarchy.
In summary, Morrow's research on SD suggests that this procedure can provide an effective procedure for reducing conditioned responses to cancer chemotherapy.
Biofeedback Combined With PMRT and Guided Imagery
Biofeedback, a commonly used treatment method in behavioral medicine, involves training an individual to control physiological responses, such as systolic blood pressure or heart rate, by using external monitoring devices. Such devices indicate when a desired change occurs, and the patient seeks to learn and then to bring under conscious control the behaviors associated with the desired change. The combined use of biofeedback, PMRT, and guided imagery with cancer chemotherapy patients has been evaluated in two studies (summarized in Table 4) . Burish, Shartner, and Lyles (1981) implemented a multiple baseline design to study the combined effectiveness of an electromyograph (EMG) biofeedback and PMRT intervention with Note. N = nausea; V = vomiting; RN = registered nurse; Pt = patient; Dx = diagnosis; CP = chemotherapy protocol; PMRT = progressive muscle relaxation training; BP = blood pressure; PR = pulse rate; EMG = electromyograph.
an adult patient who had developed psychological symptoms in response to her chemotherapy. During the four chemotherapy sessions in which the patient received the intervention and during three subsequent follow-up sessions, she showed reductions from baseline in physiological arousal and reported less anxiety and nausea. In a follow-up study, Shartner, Burish, and Carey (1985) randomly assigned 12 adults to (a) EMG biofeedback and PMRT, (b) thermal biofeedback and PMRT, or (c) a control condition. Patients were studied over five sessions. The results indicated that both forms of biofeedback, when combined with PMRT, reduced the negative affect and nausea associated with chemotherapy. Taken together, these two reports suggest that the combined use of biofeedback with PMRT and guided imagery appears to be a promising intervention. Future research might study larger samples of patients and employ a dismantling strategy (Lang, 1969) so that biofeedback can be assessed independently of PMRT and guided imagery.
Distraction Techniques
A recent innovation in the treatment of psychological side effects has involved the use of attentional diversion/cognitive distraction techniques. This treatment approach was considered because of related research in the treatment of acute pain (see McCaul & Malott, 1984) , as well as interest in the mechanism or mechanisms by which the other behavioral interventions exerted their impact (this point is addressed more fully in the Discussion section). Distraction techniques attempt to focus patients' attention on pleasant stimuli or activities, thereby directing attention away from unpleasant sensations and from potential CSs. Distraction might be achieved by any of a large number of tasks (e.g., pleasant imagery, music, focal point attention), but in the chemotherapy context, it has been most commonly accomplished by the use of external devices, particularly video games. The research using distraction to reduce the side effects of chemotherapy is described in Table 5 .
In the first published study of distraction, Kolko and Rickard-Figueroa (1985) used a multiple baseline design to study the efficacy of video games in 3 adolescent cancer patients.
When the patients used the video games, they experienced a reduction in the number of general anticipatory symptoms (e.g., nausea, insomnia, cold hands) displayed during the 24 hr prior to chemotherapy and a decrease in the aversiveness of the postchemotherapy side effects. When the games (distraction)
were not available, the number of anticipatory symptoms returned to baseline levels. Redd et al. (1987) conducted two studies to evaluate a video game-based distractor in 26 pediatric patients undergoing chemotherapy. In the first study, which used a group comparison design, these authors found a significant decrease in the intensity of nausea for those patients who employed distraction in comparison with control patients who did not. In a subsequent study, using a repeated measures reversal design (i.e., no distraction baseline, introduction to distraction, return to no dis- In the only study of distraction reported thus far with adults, Greene, Seime, and Smith (1985) were consistent with earlier reports in that video distraction initially inhibited anticipatory nausea and vomiting and that these gains were not maintained when the distractor was unavailable.
In contrast with previous work, however, the authors reported that the efficacy of distraction was attenuated with continued use (i.e., during Phase 4); moreover, the subsequent use of relaxation was associated with a reduction in anticipatory symptoms. Although a single-subject study of this sort does not warrant firm conclusions, these results do suggest that (a) the effectiveness of distraction may lessen with extended use and (b) the benefits of relaxation may be more permanent. It may be that the poor maintenance of this distractor was related to its lessening novelty, whereas the comparatively better transfer of treatment gains with PMRT (and related techniques) may result from the fact that they provide patients with a self-control technique that is more permanent (see Thoresen & Mahoney, 1974) .
Overall, preliminary research suggests that interventions that use external distractors (e.g., video games) do appear to reduce chemotherapy-related responses, at least initially, as long as the distracting stimuli are available. However, these results need to be accepted with caution until they have been replicated in controlled studies using larger patient samples. Moreover, at least four important questions are unresolved and warrant further investigation. First, does repeated use of an external distractor (e.g., video games) reduce that distractor's novelty and, therefore, efficacy over time? Second, can treatment gains achieved with external distraction be maintained after the distractor is withdrawn and the patient is left to his or her own resources?
Third, is an internally generated distractor, which can change over time and retain its novelty, be more effective than an exter-nally provided distractor, which may be more stable? And finally, how does the use of an internally generated distractor differ, if at all, from hypnosis or guided imagery? 
Summary

Factors Associated With Treatment Acceptance and Outcome
Although psychological interventions for reducing chemotherapy-related side effects are effective with many patients, they are not effective with all patients. At least two types of factors might contribute to this fact. First, not all cancer chemotherapy patients are willing to try or to continue trying psychological interventions. For example, Zeltzer et al. (1983) reported that 25% (3 of 12) of the adolescents they studied rejected hypnosis for cultural reasons. Hendler and Redd (1986) found that many chemotherapy patients believed that the hypnotic state is an unconscious, powerful state involving loss of control and that given a choice, they prefer an intervention not labeled "hypnosis." Although the other psychological interventions are less likely than hypnosis to be rejected because of misconceptions about the technique or its goals, in our research we have found that a minority of patients do not pursue these other techniques because they are perceived to involve too much effort or time. This is especially likely for patients who are very ill or weak. In some cases we believe it is possible and clinically beneficial to gently encourage such patients, using the same clinical sensitivity and skill necessary in other treatment contexts, to use the intervention.
Second, not all patients who do try psychological interventions will profit from them. For example, Lyles et al. (1982) reported that even though the majority of their patients profited from PMRT and guided imagery, some showed no change, and a few evinced increased distress on some measures. Research designed to determine whether individual patient characteristics might predict treatment outcome has helped to explain such results. In a reanalysis of data collected in an earlier series of studies, Carey and Burish (1985) found that patients who had high and moderate baseline levels of anxiety were less likely than were low-anxious patients to benefit from PMRT and biofeedback. For such persons, the task of practicing a behavioral intervention such as PMRT may be appraised as an additional stressor that increases, rather than decreases, their discomfort during chemotherapy. In a related study, reported that cancer chemotherapy patients with an external health locus of control, in comparison with patients without such an orientation, were also more likely to profit from relaxation training. In contrast, no relationship has been found between hypnotic susceptibility and the degree of symptom reduction achieved with hypnosis (Zeltzer et al., 1984b ) nor between pretreatment expectancies and outcome on systematic desensitization (Morrow & Morrell, 1982) or on PMRT . Although these results should be accepted cautiously because of the small number of patients studied, it appears that cancer chemotherapy patients who have low levels of pretreatment anxiety or who exhibit an external locus of control benefit more than do their high-anxious and nonexternally oriented counterparts. Unfortunately, no research has assessed the contribution of individual difference factors using a multivariate model in which the combined and interactive effects of several variables can be determined. It is possible that such an approach will allow us to account for a greater share of the variance in treatment outcome.
Mechanisms of Action
Given that psychological techniques can indeed be effective in reducing the conditioned and stress-induced symptoms associated with cancer chemotherapy, it is worthwhile to determine the means by which these techniques exert their impact. The identification of unique and common causal factors across interventions would be theoretically interesting and would also allow for more precise and cost-effective treatment planning.
Unfortunately, few studies have provided the comparative and componential analyses required to address directly these issues in a convincing empirical fashion. Despite this lacuna in the research literature, it is possible to describe five hypotheses that may explain, at least in part, the mechanism or mechanisms by which psychological interventions reduce chemotherapy-related distress. We preface our descriptions by acknowledging that these represent hypotheses to be evaluated rather than conclusions to be drawn.
Nonspecific factors. The first hypothesis, which must be considered in any discussion of possible mechanisms, is that the effectiveness of the treatment results from the various nonspecific factors associated with the treatment's delivery (Kazdin & Wilcoxon, 1976) . Such nonspecific factors are likely to include positive expectancies of the patient (i.e., the placebo effect; Frank, 1973) In order to test this hypothesis, several studies have included plausible attention-placebo procedures to control for nonspecific factors (e.g., Cotanch & Strum, 1985; Lyles et al., 1982; Morrow & Morrell, 1982) . In each of these investigations the specific intervention was clearly superior to the placebo condition, which in turn did not differ from the nontreatment control. Moreover, investigators who have studied antiemetic medications (see Siegel & Longo, 1981) or alternative behavior interventions (e.g., have demonstrated that positive expectancies and increased attention alone cannot account for treatment efficacy. Thus, although nonspecific factors probably do contribute to the overall impact of the treatments, it is unlikely that these factors account for much of the observed effect.
Physiological relaxation. An alternative explanation for the beneficial effects observed in the chemotherapy context is that such improvements may be attributable to deep somatic restfulness, sometimes called the relaxation response (Benson, 1975) .
This effect would appear to be produced by four of the five interventions just reviewed (viz., hypnosis, PMRT, SD, and EMG biofeedback).
5 In this regard, previous clinical research suggests that despite some differences in their effects, these stress-management procedures are quite similar in that they produce "a large global relaxation response" (Lehrer & Woolfolk, 1984, p. 463; emphasis added).
Within the chemotherapy context, relaxation may exert its effect through one or more of several related pathways, with the degree of relaxation achieved related to level of effectiveness. duce its effects by increasing the threshold (i.e., decreasing the sensitivity) of the chemoreceptor trigger zone, which is believed to coordinate the vomiting response (Borison & McCarthy, 1983) .
Although these hypotheses are speculative, indirect support for their validity is provided by the following general findings.
First, many antiemetic medications (e.g., prochlorperazine) are effective in reducing emesis in part because they produce a physiological sedation effect (Borison & McCarthy, 1983 ) that may be similar to, although stronger than, that produced by behavioral relaxation techniques (cf. Lader, 1984) . Second, there is ample evidence from other clinical contexts that relaxation produces a general decrease in sympathetic arousal and EMG activity (Borkovec & Sides, 1979) . Finally, Hoffman et al. (1982) have reported that relaxation can result in augmented plasma norepinephrine levels, particularly under conditions of stress. These authors speculated that individuals skilled at deep relaxation are physiologically less responsive to stress, with reduced adrenergic end-organ responsivity. Overall, therefore, the data suggest that deep physiological relaxation may be an active ingredient contributing to the reduction of conditioned and stress-related responses to chemotherapy.
Despite this support for the relaxation mechanism, some research suggests that physiological relaxation cannot explain completely the effectiveness of all the interventions that have been used. Specifically, Kolko and Rickard-Figueroa (1985) and Redd et al. (1987) reported that even patients who exhibited none of the signs of deep relaxation were able to reduce chemotherapy-related symptoms by becoming actively involved in video games. In addition, research by Morrow (1986) suggests that relaxation training alone is not as effective as training that included imagery components.
Cmmterconditioning. A third explanation for the efficacy of the various treatments, given that many of the symptoms experienced in the chemotherapy setting probably develop through an associative learning process, is counterconditioning. According to this explanation, the pairing of conditioned stimuli (e.g., the sight of the nurse) that formerly elicited nausea and vomiting with feelings of relaxation and comfort counterconditions these stimuli so that in the future they will elicit relaxation, or at least a less stressful state, rather than nausea and vomiting.
Direct support for this hypothesis comes from research on SD (Morrow & Morrell, 1982) ; indirect support can be gleaned from research on the other interventions (viz., hypnosis, PMRT, and biofeedback), but only if one makes the assumption that patients were aware of the conditioned stimuli present in the chemotherapy environment while they were undergoing the various psychological treatments. If this assumption is valid, it is possible to construe these alternative interventions as a form of in vivo desensitization, whereas Morrow and MorreH's (1982) use of SD can be viewed as the traditional Wolpean version of desensitization.
Although it is an attractive explanation, several problems can be raised with the counterconditioning hypothesis. First, the as-sumption that patients are attending to the conditioned stimuli present in the chemotherapy context while undergoing hypnosis or PMRT seems dubious; if they are not attending to such conditioned stimuli, then it is less likely that they are being counterconditioned. Second, from a theoretical perspective, it would seem difficult to establish a new association between the CS and the new response (e.g., relaxation) when a host of negative pharmacological side effects (i.e., the UCR) continue to occur after each chemotherapy treatment. Finally, even if these problems were not present, the effects of SD, even in the wellcontrolled laboratory setting, cannot be attributed completely to counterconditioning, because there are numerous other mechanisms, including those presented here, that appear to be operative (cf. Masters et ah, 1987; McGlynn, Mealiea, & Landau, 1981) . Attentional diversion or redirection. All five of the behavioral interventions reviewed earlier require that patients participate cognitively in the intervention, usually by attending to relaxing or at least nonanxiety-producing situations. It may be that such attentional diversion or redirection may be mediating the therapeutic effect of the various interventions; that is, with patients attending to interesting external (e.g., video games) or internal (e.g., pleasant imagery) stimuli, there is less attention available to focus on unpleasant internal sensations (e.g., nausea) or potential CSs (e.g., drug taste). Such attentional diversion might also be understood from a "stress and coping" perspective (e.g., Lazarus & Folkman, 1984) ; that is, if the distracting task is enjoyable (as with pleasant imagery or the use of video games), then appraisal of the overall aversiveness (i.e., threat) of chemotherapy may be lessened, resulting in less dysphoria. This is true even if the distractor produces increased physiological arousal, which results from video games (Redd et ah, 1987) . Such arousal is believed to result from positive emotions, such as excitement, or from physical effort that is part of the game rather than from a distressing situation (although, conceivably, an improperly chosen distractor could become distressing, such as a video game that was too difficult or produced feelings of failure). Thus, even though some distractors may increase physiological arousal, they can focus attention on a pleasant task and thereby decrease distress.
Direct empirical support for the distraction hypothesis comes from the three reports described earlier (i.e., Greene et ah, 1985; Kolko&Rickard-Figueroa, 1985; Redd etah, 1987) . Indirect support for the distraction hypothesis comes from research with other procedures (i.e., hypnosis, PMRT with guided imagery, biofeedback, and systematic desensitization), which all require that the patient attend to specific instructions or actively participate in certain procedures while undergoing chemotherapy.
6 These instructions and procedures are typically quite absorbing of cognitive capacity, especially to the extent that patients are motivated and interested. Morrow's (1986) study can be seen as supporting this position in that he found that PMRT was not effective when guided imagery was not used during the infusion time; that is, Morrow's version of PMRT may have required less of the patients' attention during their chemotherapy and was, as a result, less efficacious than was this procedure in other studies in which patients did use imagery during the infusion (e.g., Lyles et ah, 1982) . There is one study that did not support the use of distraction: Cotanch and Strum (1985) reported that listening to audiotapes of music was not successful in reducing the aversiveness of chemotherapy. Perhaps the distractor used in this study was not sufficiently engaging; that is, listening to music may not have occupied completely the patients' cognitive capacity, which is a necessary characteristic of effective cognitive distractors (see McCaul & Malott, 1984) . In summary, attentional diversion or cognitive distraction may play an important role in reducing psychological side effects. Enhanced perception of self-efficacy and mastery. In one way or another, all of the treatments discussed afford patients an active coping strategy (cf. Goldfried, 1971; Goldfried & Trier, 1974) and may produce in patients an increased sense of selfefficacy or of perceived mastery (see Bandura, 1977) . Morrow and MorreU's (1982) modified SD procedure, for example, has patients imagining themselves staying relaxed and calm in situations that formerly caused considerable anxiety. PMRT and hypnosis procedures show patients how to relax in the midst of a busy chemotherapy treatment room, seated in the treatment chair, with the tray of syringes at their side. Attentional diversion techniques illustrate how the patients can control their attention so as to virtually ignore and thereby render impotent the conditioned stimuli in the environment. The confidence developed when a person believes that the use of an intervention will allow control over a stressful situation may, in the chemotherapy context as in many other contexts, be an important ingredient of the treatment package.
It may be said that the data on health locus of control, a concept related to perceived mastery, do not support the enhanced self-efficacy explanation. For example, Morrow and Morrell (1982) found that reductions in anticipatory nausea and vomiting were not accompanied by corresponding changes in health locus of control. Also, we (Burish et ah, 1984) have found that chemotherapy patients with a high external health locus of control orientation are more likely to benefit from a treatment intervention than are patients low on this dimension. Although our data appear to weaken the perceived mastery explanation (Burish et ah, 1984) , upon reflection, this may not be so: health locus of control measures a person's view of where the locus of control lies, not whether there is control or whether one desires or has control. Indeed, even if the control lies in a source external to one's self (e.g., in a videotape or a psychologist's suggestions), by availing oneself of that source of control, one could clearly come to believe that mastery can be achieved. Although the role of perceived mastery and self-efficacy is hypothetical at this point, it warrants continued empirical investigation.
6 Systematic desensitization may be thought to involve cognitive participation only during training; because SD training has typically occurred outside of the chemotherapy context, it would appear that SD does not involve a distracting component during the actual chemotherapy infusion. Alternatively, however, SD may involve a distraction component during chemotherapy if patients are actively using the relaxation procedures that they learned during training as a way of managing discomfort, distress, or both resulting from venipuncture, the infusion, or other chemotherapy procedures. In this case, SD would appear to involve an active distraction component.
Conclusion. Five different mechanisms have been proposed
in order to explain the efficacy of psychological interventions for the reduction of conditioned and stress-related responses in cancer chemotherapy. At this stage, the comparative research needed to answer the question, "How do these treatments exert their impact?", is incomplete. Nonetheless, on the basis of the limited research that has addressed this question, either directly or indirectly, we conclude that it is unlikely that any single mechanism adequately accounts for the beneficial effects that have been observed in this context. Rather, we suggest that these different mechanisms should be viewed as cooperating and interacting to produce an effect rather than as competing hypotheses. A related interpretation is that the different mechanisms proposed herein reflect different levels of analysis in a biopsychosocial framework (cf. Engel, 1977; Schwartz, 1982) .
Clinical Issues
In previous reviews of the literature (e.g., Redd & Andrykowski, 1982) , several important clinical issues were discussed, including (a) choosing among the various interventions, (b) promoting maintenance of treatment gains, and (c) identifying individuals at risk for not profiting from psychological interventions and developing approaches to meet their special needs. These issues continue to be important, but in this article we discuss four additional issues that have emerged in recent years.
First, to date, most work concerned with nausea and vomiting in cancer patients has been either biomedical or psychosocial in nature. Many psychosocial researchers regard pharmacological (i.e., antietnetic) treatments as nuisance variables requiring methodological control. Similarly, biomedical researchers have neglected important psychosocial issues (Carey, Burish, & Brenner, 1983) . The time has come for biomedical and psychosocial research on nausea and vomiting to be integrative and complementary, with the goal being to develop the best possible treatment package. A psychological intervention that commences prior to the initiation of chemotherapy, combined with an effective drug protocol that balances antiemetic protection with toxic side effects, may be able to prevent or substantially reduce most nausea and vomiting associated with chemotherapy. Interdisciplinary (i.e., biopsychosocial; Engel, 1977; Schwartz, 1982) research of this nature is clearly desirable.
Second, in order for psychological interventions to be used widely in cancer clinics and hospitals throughout the country, a more favorable cost-effectiveness ratio is needed. Most cancer clinics do not use psychological interventions, even though they may be aware of their efficacy, because of the monetary costs and time involved (usually several hours per patient) or the lack of available and trained therapists. We recently completed a study to determine whether our PMRT and guided imagery intervention could be delivered as effectively by audiotapes or by trained paraprofessionals as by experienced psychologists . Unfortunately, our data suggest that the experienced therapists were significantly more effective than the other service delivery techniques, which dampens our enthusiasm for these alternate approaches as cost-effective solutions. The modified SD procedure used by Morrow and Morrell (1982) requires perhaps the least amount of intervention time (about 2 hr), but outcome data are not available beyond two postintervention sessions. Distraction has the potential of being a cost-effective approach, although it may be necessary to insure that external distractors are always available to patients, at home and in the clinic. Clearly, low-cost delivery techniques are needed in order to make the current technology available to the majority of chemotherapy patients who could benefit from it.
Third, in some settings and for some types of chemotherapy treatment protocols, nausea and vomiting have become less problematic in recent years. For example, Stefanek, Sheidler, and Petting (1988) compared the prevalence and severity rates of anticipatory symptoms reported by adult patients in their clinic in 1987 with those of approximately 5 years earlier. In general, they found that while the prevalence rates were similar, the severity ratings were lower; that is, there was a significant decrease in severity from the first to the second sampling, with the more recent ratings indicating that anticipatory nausea and vomiting were no longer "a significant clinical problem" for patients receiving parenteral chemotherapy. We have also noticed a decline in the severity of these side effects, as well as a decreased prevalence, in adult patients seen in our clinic . Moreover, we anticipate that this trend may continue, at least in adults, largely because of the development of antiemetic drugs that are less toxic and more effective and because of the increased availability of these medications beyond major medical centers. If we assume that this trend is occurring and does continue, will this mean that in the future there will be less need for psychological interventions with chemotherapy patients? We believe the answer is no. But these data and observations, and reports of the side effects of newer forms of cancer treatments (e.g., interleukin-2), do suggest that the focus of the psychological interventions may need to change. As this review has shown, most of the psychological research with chemotherapy patients has focused on nausea and vomiting as the only or the primary outcome measures. However, psychological interventions can have a positive effect on a number of other symptoms that chemotherapy patients experience, including negative emotional states (Lyles et al., 1982) , reduced food intake (Campbell, Dixon, Sanderford, & Denicola, 1984) , and pain (Spiegel, 1985) . Future researchers might do well to broaden both the symptoms that are targeted and the outcome measures that are assessed. We suspect that such an approach will ultimately provide even stronger support for the use of psychological interventions with cancer patients.
Finally, research on the treatment of psychological responses to cancer chemotherapy has progressed to a point at which oneshot, noncontrolled studies will usually contribute little, empirically or heuristically, to the area. Advances will depend increasingly upon controlled studies that build upon prior findings. Comparative studies, and studies using a dismantling design in order to clarify treatment mechanisms, hold much promise. And, as indicated earlier, continued research on the etiology of conditioned and stress-related responses to cancer chemotherapy is warranted.
Conclusion
On the basis of the data reviewed, it can be concluded that the psychological symptoms that result from cancer chemotherapy appear to be the product of both associative learning and the stress associated with chemotherapy. Moreover, these side effects can, in many instances, be prevented or ameliorated with psychological techniques. This conclusion is based on research conducted in a variety of clinics, on children and adults, by independent research teams, using poorly controlled as well as well-controlled methodological designs. Overall, therefore, these findings can be considered robust.
Although considerable knowledge has been generated in a short period of time, and although the rate of publications continues to increase, we believe that research on the psychological treatment of the side effects of cancer chemotherapy is at a critical point in its development. The use of progressively less toxic and more effective antiemetic drugs, the increased emphasis on cost-effectiveness, and the methodological and scientific evolution of the field will demand changes in the strategies and approaches used by psychosocial investigators. For example, a focus on why some people do not benefit from psychological treatments might prove useful theoretically and clinically, as might more integrative, comprehensive treatment packages that include pharmacological components and that attempt to do more than reduce anticipatory nausea and vomiting. Such studies will help to insure that research on the treatment of psychological side effects of cancer chemotherapy continues to make significant theoretical and clinical advances.
